Roelof van Ewijk

12PUBLICATIONS
115CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 18, 2025
Preliminary Surgical Findings and Complications After National Centralization of Pediatric Bone Sarcoma Resections in the Netherlands: A Benchmarking Study.

Lorenz H M van Schalkwijk, Jasper M van der Zee, Roelof van Ewijk

|Jul 29, 2025
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic review.

Alba Rubio-San-Simón, William Wilson, Giovanna Sironi

|May 29, 2025
Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma.

Roelof van Ewijk, Laura S Hiemcke-Jiwa, Jayne Y Hehir-Kwa

|Jan 24, 2025
The prognostic value of baseline EARL standardized FDG PET indices in pediatric and adolescent high-grade osteosarcoma.

Roelof van Ewijk, Rana Dandis, Janna Rodewijk

|Oct 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998.

Julia Chisholm, Henry Mandeville, Madeleine Adams

|Jun 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.

Darrell Green, Roelof van Ewijk, Elisa Tirtei

Pageof 2

Frequent Collaborators

6 joint publications

Johannes H M Merks

5 joint publications

Rick R van Rijn

3 joint publications

Reineke A Schoot

3 joint publications

Simone A J Ter Horst